Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The recruitment status changes to no longer looking for participants. The page revision is updated to v3.6.0 (from v3.5.5).
    Difference
    0.2%
    Check dated 2026-06-15T06:00:52.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.5.5 replacing the previous v3.5.4, indicating a new revision of the record.
    Difference
    0.1%
    Check dated 2026-06-08T03:49:05.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.4) was added to the study record history, and the previous revision (v3.5.3) was removed from the history listing.
    Difference
    0.1%
    Check dated 2026-05-17T10:39:33.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    A minor ClinicalTrials.gov page revision/version update changes the displayed “Revision: v3.5.x” label from v3.5.2 to v3.5.3 without altering the trial record’s substantive details.
    Difference
    0.1%
    Check dated 2026-04-25T18:55:26.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new 'Study Status' entry was added to the history, and the record was upgraded to Revision v3.5.2, while the older Revision v3.5.0 was removed.
    Difference
    0.3%
    Check dated 2026-04-18T13:46:46.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed in the history. This looks like a system update with no changes to the study information visible on the page.
    Difference
    0.1%
    Check dated 2026-03-21T00:45:18.000Z thumbnail image

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.